{"title":"[选择性手术前停用华法林后肝素给药机构指南的依从性和问题]。","authors":"Tomomichi Koga, Yuka Shibata, Masashi Kawamoto","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We established local guidelines of heparin bridging therapy. However, it is unknown how adherence to our guidelines was achieved and whether our guidelines improved adherence compared with other universal guidelines.</p><p><strong>Methods: </strong>A retrospective chart review was con- ducted on compliance with 3 recommendations in the guidelines; these are initial unfractioned heparin dose, timing of unfractioned heparin administration, and two times measurements of activated partial thromboplas- tin time (APTT). We compared 3 recommendations in the guidelines with platelet monitoring which is not described in the guidelines. We also investigated bleed- ing and thromboembolic events during heparin bridg- ing therapy according to the guidelines.</p><p><strong>Results: </strong>Initial unfractioned heparin dose, timing of unfractioned heparin administration, measurements of APTT, and platelet monitoring were concordant with the guidelines in 78.9%, 19.7%, 67.6%, and 46.5%, respectively. Bleeding events occurred in 3 cases, but no thromboembolic events occurred. Adherence to rec- ommendations for timing of unfractioned heparin administration was the lowest and significantly lower than platelet monitoring.</p><p><strong>Conclusions: </strong>Our local guidelines were partially effective to improve adherence We have to alert phy- sicians to care bleeding complications during heparin bridging therapy in our hospital.</p>","PeriodicalId":18254,"journal":{"name":"Masui. The Japanese journal of anesthesiology","volume":"66 4","pages":"456-462"},"PeriodicalIF":0.0000,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Adherence to and Issues on our Institutional Guidelines on Heparin Administration after Withdrawal of Warfarin before Elective Surgery].\",\"authors\":\"Tomomichi Koga, Yuka Shibata, Masashi Kawamoto\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>We established local guidelines of heparin bridging therapy. However, it is unknown how adherence to our guidelines was achieved and whether our guidelines improved adherence compared with other universal guidelines.</p><p><strong>Methods: </strong>A retrospective chart review was con- ducted on compliance with 3 recommendations in the guidelines; these are initial unfractioned heparin dose, timing of unfractioned heparin administration, and two times measurements of activated partial thromboplas- tin time (APTT). We compared 3 recommendations in the guidelines with platelet monitoring which is not described in the guidelines. We also investigated bleed- ing and thromboembolic events during heparin bridg- ing therapy according to the guidelines.</p><p><strong>Results: </strong>Initial unfractioned heparin dose, timing of unfractioned heparin administration, measurements of APTT, and platelet monitoring were concordant with the guidelines in 78.9%, 19.7%, 67.6%, and 46.5%, respectively. Bleeding events occurred in 3 cases, but no thromboembolic events occurred. Adherence to rec- ommendations for timing of unfractioned heparin administration was the lowest and significantly lower than platelet monitoring.</p><p><strong>Conclusions: </strong>Our local guidelines were partially effective to improve adherence We have to alert phy- sicians to care bleeding complications during heparin bridging therapy in our hospital.</p>\",\"PeriodicalId\":18254,\"journal\":{\"name\":\"Masui. The Japanese journal of anesthesiology\",\"volume\":\"66 4\",\"pages\":\"456-462\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Masui. The Japanese journal of anesthesiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Masui. The Japanese journal of anesthesiology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Adherence to and Issues on our Institutional Guidelines on Heparin Administration after Withdrawal of Warfarin before Elective Surgery].
Background: We established local guidelines of heparin bridging therapy. However, it is unknown how adherence to our guidelines was achieved and whether our guidelines improved adherence compared with other universal guidelines.
Methods: A retrospective chart review was con- ducted on compliance with 3 recommendations in the guidelines; these are initial unfractioned heparin dose, timing of unfractioned heparin administration, and two times measurements of activated partial thromboplas- tin time (APTT). We compared 3 recommendations in the guidelines with platelet monitoring which is not described in the guidelines. We also investigated bleed- ing and thromboembolic events during heparin bridg- ing therapy according to the guidelines.
Results: Initial unfractioned heparin dose, timing of unfractioned heparin administration, measurements of APTT, and platelet monitoring were concordant with the guidelines in 78.9%, 19.7%, 67.6%, and 46.5%, respectively. Bleeding events occurred in 3 cases, but no thromboembolic events occurred. Adherence to rec- ommendations for timing of unfractioned heparin administration was the lowest and significantly lower than platelet monitoring.
Conclusions: Our local guidelines were partially effective to improve adherence We have to alert phy- sicians to care bleeding complications during heparin bridging therapy in our hospital.